Compound management is an important and vital part of any organization focused on the development of small molecules for therapeutic use. However, this critical infrastructure is often overlooked in the earliest stages of a company’s growth, which can result in significant challenges for scientists and programs as the company matures.
Accent Therapeutics was founded in 2017 as a company focused on developing small molecule inhibitors targeting RNA-modifying proteins using a mixed model of internal and external scientific resources. From its initiation, Accent prioritized resources towards the development of infrastructure (personnel, instrumentation, software, and CRO partners) to support the changing compound management needs of the company as Accent grew in personnel and programs.
In this webinar, Gina Prophete, manager of sample management at Accent Therapeutics, will discuss the past and current stages of Accent’s compound management growth, as well as future plans for infrastructure improvements.
To access the full webinar, complete the form on the left.